Form D · Other
Critical Reagent Processing Corp.
Vancouver, A1 · CIK 0001823126
Offering snapshot reported Feb 10, 2026 · SEC filing
- Reported sold
- $44.6K Offering amount: $44.6K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 9, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 10, 2026 | Initial | $44,550 | No comparison | 1 | SEC filing |
| Sep 1, 2022 | Amendment | $102,976 | $0vs Sep 1, 2020 | 5 | SEC filing |
| Mar 31, 2022 | Initial | $67,989 | No comparison | 2 | SEC filing |
| Sep 1, 2020 | Initial | $102,976 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573060
The US dollar amounts are based on the Bank of Canada average rate of exchange reported on Feb. 9, 2026, which was USD$1.00 = CAD$1.3576.
Source: Form D, filed Feb 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Teresa Cherry | Director, Executive |
| Christopher Cherry | Director |
| William (Bill) Feyerabend | Director |
| William Feyerabend | Director |
| Adrian Hobkirk | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1681 Chestnut Street Suite 400
Vancouver, A1, V6J 4M6
Vancouver, A1, V6J 4M6